Cargando…

The Cost of Locally Advanced Cervical Cancer in Thailand: an Empirical Study for Economic Analysis

OBJECTIVE: To evaluate cost of illness of locally advanced cervical cancer patients from societal perspective in three scenarios including completely cured without severe late side effects (S1), completely cured with late grade 3-4 gastrointestinal side effects (S2.1) or genitourinary side effects (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Katanyoo, Kanyarat, Riewpaiboon, Arthorn, Chaikledkaew, Usa, Thavorncharoensap, Montarat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858260/ https://www.ncbi.nlm.nih.gov/pubmed/34710993 http://dx.doi.org/10.31557/APJCP.2021.22.10.3171

Ejemplares similares

Cost-Effectiveness Analysis of Diagnostic Tests for Para-Aortic Lymph Node Detection in Locally Advanced Cervical Cancer
por: Katanyoo, Kanyarat, et al.
Publicado: (2021)

The economic costs of alcohol consumption in Thailand, 2006
por: Thavorncharoensap, Montarat, et al.
Publicado: (2010)

Economic impact of medical genetic testing on clinical applications in Thailand
por: Jittikoon, Jiraphun, et al.
Publicado: (2020)

Economic burden of childhood diarrhea in Burundi
por: Niyibitegeka, Fulgence, et al.
Publicado: (2021)

Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines
por: Briones, Jamaica Roanne, et al.
Publicado: (2020)

A drug cost model for injuries due to road traffic accidents
por: Riewpaiboon, Arthorn, et al.
Publicado: (2008)

Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children
por: Riewpaiboon, Arthorn, et al.
Publicado: (2010)

The economic impact of alcohol consumption: a systematic review
por: Thavorncharoensap, Montarat, et al.
Publicado: (2009)

Treatment cost and costing model of obstetric complications at a hospital in Myanmar
por: Shwe, A. Thi Win, et al.
Publicado: (2019)

Incremental Net Monetary Benefit of Bariatric Surgery: Systematic Review and Meta-Analysis of Cost-Effectiveness Evidences
por: Noparatayaporn, Prapaporn, et al.
Publicado: (2021)

Social and economic burden of patients with influenza-like illness and clinically diagnosed flu treated at various health facilities in Vietnam
por: Quang Vo, Trung, et al.
Publicado: (2017)

Economic evaluation of hepatitis A vaccines by income level of the country: A systematic review
por: Gurav, Yogesh Kirshnarao, et al.
Publicado: (2022)

Systematic Review and Meta-Analysis of Cost-effectiveness of Rotavirus Vaccine in Low-Income and Lower-Middle-Income Countries
por: Haider, Sabbir, et al.
Publicado: (2019)

Economic costs of alcohol use in Sri Lanka
por: Ranaweera, Sajeeva, et al.
Publicado: (2018)

Factors affecting health-related quality of life in Thai children with thalassemia
por: Thavorncharoensap, Montarat, et al.
Publicado: (2010)

Economic costs of obesity in Thailand: a retrospective cost-of-illness study
por: Pitayatienanan, Paiboon, et al.
Publicado: (2014)

Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam
por: Due, Ong The, et al.
Publicado: (2020)

Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer’s Perspective
por: Bagepally, Bhavani Shankara, et al.
Publicado: (2021)

Clinical Impact of Pelvic Lymph Node Status in Locally Advanced Cervical Cancer Patients Treated by Concurrent Chemoradiation Therapy
por: Katanyoo, Kanyarat, et al.
Publicado: (2021)

Predicting Treatment Cost for Bacterial Diarrhoeaat a Regional Hospital in Thailand*
por: Riewpaiboon, Arthorn, et al.
Publicado: (2008)

Economic evaluation of population-based type 2 diabetes mellitus screening at different healthcare settings in Vietnam
por: Toi, Phung Lam, et al.
Publicado: (2021)

Economic Evaluation of Screening Strategy for Latent Tuberculosis Infection (LTBI) in Contacts of Tuberculosis Patients: Systematic Review and Quality Assessment
por: Yoopetch, Panida, et al.
Publicado: (2022)

Economic cost of patients with trisomy 13, 18, and 21 in a tertiary hospital in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023)

Cost-utility analysis of treatments for stage IB cervical cancer
por: Katanyoo, Kanyarat, et al.
Publicado: (2014)

Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion
por: Katanyoo, Kanyarat
Publicado: (2017)

Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis
por: Yoopetch, Panida, et al.
Publicado: (2023)

Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
por: Sangroongruangsri, Sermsiri, et al.
Publicado: (2021)

Cost-Utility Analysis of Molecular Testing for Tuberculosis Diagnosis in Suspected Pulmonary Tuberculosis in Thailand
por: Chitpim, Natthakan, et al.
Publicado: (2022)

Economic evaluation of prenatal screening for fetal aneuploidies in Thailand
por: Wongkrajang, Preechaya, et al.
Publicado: (2023)

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
por: Aungsumart, Saharat, et al.
Publicado: (2023)

Cost-Utility Analysis of Community Case Management for Malaria Control in Burundi
por: Hezagira, Nina, et al.
Publicado: (2022)

Economic cost of tobacco-related cancers in Sri Lanka
por: Amarasinghe, Hemantha, et al.
Publicado: (2018)

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
por: Tantai, Narisa, et al.
Publicado: (2014)

Influenza vaccination in acute coronary syndromes patients in Thailand: the cost-effectiveness analysis of the prevention for cardiovascular events and pneumonia
por: Sribhutorn, Apirak, et al.
Publicado: (2018)

What criteria do decision makers in Thailand use to set priorities for vaccine introduction?
por: Pooripussarakul, Siriporn, et al.
Publicado: (2016)

Advanced health biotechnologies in Thailand: redefining policy directions
por: Velasco, Román Pérez, et al.
Publicado: (2013)

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand
por: Leelahavarong, Pattara, et al.
Publicado: (2010)

Exploring cost drivers to improve disease management: the case of type 2 diabetes at a tertiary hospital in Burundi, Africa
por: Hezagirwa, Benitha, et al.
Publicado: (2023)

Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
por: Thavorncharoensap, Montarat, et al.
Publicado: (2013)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cd885btftuck0n7hnov1ctd3c1